|4Jul 3, 4:28 PM ET

Caplan Vered 4

4 · Orgenesis Inc. · Filed Jul 3, 2018

Insider Transaction Report

Form 4
Period: 2018-06-28
Caplan Vered
Director
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2018-06-28+250,000250,000 total
    Exercise: $8.36From: 2018-12-28Exp: 2028-06-28Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The options were awarded under the Issuer's 2017 Equity Incentive Plan and are scheduled to vest in two equal installments of 125,000 option shares on each of December 28, 2018 and June 28, 2019 and are exercisable at a per share exercise price of $8.36.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES